William S Marth Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William S Marth.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William S Marth. William S Marth is a Director in Teligent, Inc. ($TLGT) and a Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and a President and CEO in ALBANY MOLECULAR RESEARCH INC ($AMRI) and a Director in Sorrento Therapeutics, Inc. ($SRNE).
Address: 21 CORPORATE CIRCLE PO BOX 15098 ALBANY 12033 NY
Companies in which William S Marth is an Insider
ALBANY MOLECULAR RESEARCH INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of William S Marth: President and CEO, Director
Holdings: 503,416 shares
Current Value: $9,282,991
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sorrento Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of William S Marth: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 12 2016
$SRNE Market Capitalization: $312.87M
$SRNE Previous Close: $5.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Teligent, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William S Marth: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 24 2021
$TLGT Market Capitalization: $375.06M
$TLGT Previous Close: $6.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of William S Marth
Sentiment: All, AMRI, SRNE, TLGT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | TLGT | Teligent, Inc. | Marth William S | Director | Option Exercise | A | 1.36 | 2,000 | 2,720 | 2,000 | |
| Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 18.41 | 133,690 | 2,461,233 | 0 | |
| Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 15.77 | 54,498 | 859,433 | 0 | |
| Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | D | 21.75 | 483,033 | 10,505,968 | 0 | 483 K to 0 (-100.00 %) |
| Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 20,383 | 0 | 483,033 | 503.4 K to 483 K (-4.05 %) |
| Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 18,472 | 0 | 503,416 | 521.9 K to 503.4 K (-3.54 %) |
| Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 16.04 | 884 | 14,179 | 521,888 | 521 K to 521.9 K (+0.17 %) |